We're pleased to report that MacroGenics shareholders have received a total shareholder return of 57% over one year. That certainly beats the loss of about 12% per year over the last half decade. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 2 warning signs for MacroGenics (1 shouldn't be ignored) that you should be aware of.